LONDON, United Kingdom (AFP) – British pharmaceuticals giant AstraZeneca on Monday revealed more positive results from a trial of a treatment for Covid-19 symptoms. The drug, made from a combination of two antibodies, achieved a “statistically significant reduction in severe Covid-19 or death” in non-hospitalised patients with mild-to-moderate symptoms, AstraZeneca said in a statement. The group’s treatment, known as AZD7442, has been undergoing phase 3 or final clinical trials to assess its safety and efficacy. […]